Skip to content

The safety and efficacy of laparoscopic para-aortic lymph node dissection for Ovarian Cancer

The safety and efficacy of laparoscopic para-aortic lymph node dissection for Ovarian Cancer - The safety and efficacy of laparoscopic para-aortic lymph node dissection for Ovarian Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032410
Enrollment
10
Registered
2018-04-27
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

laparoscopic para-aortic lymph node dissection

Sponsors

Mie University Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Ovarian cancer stage 1-2. Patients who have no desire to have more child. Positive pelvic lymph node metastasis by diagnostic imaging.

Exclusion criteria

Exclusion criteria: Obesity. Severe endometriosis. Patient with severe complication.

Design outcomes

Primary

MeasureTime frame
safety and efficacy

Secondary

MeasureTime frame
adverse event and reccurence

Countries

Japan

Contacts

Public ContactEiji Kondo

Mie University Faculty of Medicine Department of Obstetrics and Gynecology

eijikon@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026